homocysteine has been researched along with Ovarian Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanco-González, E; Cinti, M; Fernández de la Campa, MR; Iglesias González, T; Montes-Bayón, M | 1 |
| Bukhari, SA; İbrahim, Z; Javed, S; Rajoka, M; Sadiq, R; Zafar, K | 1 |
| Lukyanova, NY | 1 |
| Boiocchi, M; Corona, G; Innocenti, F; Mini, E; Russo, A; Sartor, F; Toffoli, G; Tumolo, S | 1 |
| Boiocchi, M; Corona, G; Donada, C; Fabris, M; Toffoli, G; Viel, A; Zarrelli, A | 1 |
| Hogenkamp, HP; Hrushesky, WJ; Roelofs, R; Trugman, J | 1 |
6 other study(ies) available for homocysteine and Ovarian Neoplasms
| Article | Year |
|---|---|
Reversed phase and cation exchange liquid chromatography with spectrophotometric and elemental/molecular mass spectrometric detection for S-adenosyl methionine/S-adenosyl homocysteine ratios as methylation index in cell cultures of ovarian cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Chromatography, Reverse-Phase; Cisplatin; DNA Methylation; Drug Resistance, Neoplasm; Female; Homocysteine; Humans; Methylation; Molecular Weight; Ovarian Neoplasms; S-Adenosylhomocysteine; S-Adenosylmethionine; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2015 |
Oxidative stress-induced DNA damage and homocysteine accumulation may beinvolved in ovarian cancer progression in both young and old patients.
Topics: Antioxidants; DNA Damage; Female; Homocysteine; Humans; Ovarian Neoplasms; Oxidative Stress | 2016 |
Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cadherins; Carcinoma; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Homocysteine; Humans; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2 | 2010 |
Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; DNA Primers; Female; Genotype; Hematologic Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Oxidoreductases Acting on CH-NH Group Donors; Platelet Count; Polymerase Chain Reaction; Polymorphism, Genetic | 2003 |
Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells.
Topics: Adult; Aged; Ascitic Fluid; Cysteine; Female; Folic Acid; Glycine; Homocysteine; Humans; Methionine; Methylation; Middle Aged; Ovarian Neoplasms; Vitamin B 12 | 1997 |
Cisplatin neurotoxicity: failure to demonstrate vitamin B12 inactivation.
Topics: Analysis of Variance; Circadian Rhythm; Cisplatin; Cobamides; Female; Homocysteine; Humans; Infusions, Parenteral; Methylmalonic Acid; Ovarian Neoplasms; Urinary Bladder Neoplasms; Vitamin B 12; Vitamin B 12 Deficiency | 1985 |